skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

99+ Total results for product and free and sample content found


The Impact of Covid-19 on B2B Marketers

When circumstances make meeting in person an impossibility, Skipta Gather is there. Don’t miss out on reaching your target audience because travel is curtailed and meetings are cancelled. Use Skipta Gather to conduct virtual sessions with verified physicians and get the job done.

Topic Advertising, Marketing & Sales

Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biom...

COVID-19 and the impact on the clinical trial space

COVID-19 and the impact on the clinical trial space

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Topic Coronavirus clinical-trials

awareness, Pharma consulting: 医療用医薬品のコンサルティング

Hunting for Cancer Neoantigens : What is the best approach?

Important insights into neoantigen-based immunotherapies and which developers are leading in this growing area.

Topic cancer clinical-trial-optimization

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine logo

Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.

Topic Coronavirus Vaccines

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Gilead Sets Remdesivir Price Commits Nearly All Near-Term Supplies To US

A five-day course will cost $2,340 for governments in developed countries and $3,120 for commercial payers. The US will get 100% of remdesivir manufactured by Gilead in July. 

Topic Coronavirus

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

COVID-19 24-hour web event: Lessons learned and a path forward

Join our free 24-hour interactive webinar series on 21 July that will cover the latest insights and learning on COVID-19 from across the global Pharma and Biomedtech industry.

Topic Coronavirus

HBW Insight : コンシューマーヘルスケア産業のニュース

Health, Beauty and Wellness Coronavirus Coverage

The COVID-19 pandemic has impacted the consumer health and beauty products industries in different ways, and HBW Insight covers it all. We deliver all the latest regulatory, legislative, legal and commercial developments across the over-the-counter medicine, dietary supplement and the cosmetics sectors to keep you informed and strategically on target.

Topic Coronavirus

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

New Leader & Reorgs at Key Regulatory Agencies

Pink Sheet invites you to go inside the recent personnel changes at key regulatory agencies around the globe – including US FDA, EMA, and England’s NICE – and how these new appointments will likely influence future regulation of the biopharma industry.

Topic Regulation





電話:+81 (0)3 6273 4260